Activated CD21 low CD38- Abs

Optimal result: 3 – 26 cells/mcL

Elevated levels of "Activated CD21 low CD38- Abs" indicate a shift in the population of B cells that may be linked to various immune system responses, particularly in the context of immune activation or dysregulation.

Here’s a breakdown of what this might suggest:

  • CD21: This is a receptor found on B cells that normally helps in the regulation of immune responses, particularly in the activation of B cells through interactions with the complement system. A low CD21 expression on B cells suggests that these cells have undergone activation and are no longer in their resting or naive state.

  • CD38: CD38 is another cell surface marker, typically found on activated B cells, and plays a role in signaling pathways that regulate B cell differentiation and survival. CD38- means that these cells do not express CD38, suggesting that while they are activated (due to low CD21), they are not fully differentiated or in the later stages of activation (like plasma cells).

What Elevated Levels Could Indicate:

  1. Chronic Inflammation or Immune Activation: Elevated levels of activated CD21 low CD38- B cells might point to a state of chronic immune activation or ongoing inflammation. This could be seen in conditions like autoimmune diseases, chronic infections, or inflammatory disorders, where B cells are continuously activated.

  2. Autoimmune Diseases: Conditions like lupus, rheumatoid arthritis, or Sjögren’s syndrome might result in the activation of B cells in a dysregulated manner. The lack of CD21 expression can be seen in some autoimmune disease settings, indicating B cell activation in the context of a self-directed immune response.

  3. Immune Dysregulation: This could be an indication of dysregulated immune responses, where the immune system is overactive or malfunctioning. For example, in diseases like systemic lupus erythematosus (SLE), B cells may become abnormally activated, even in the absence of infection.

  4. Chronic Infections: Some chronic infections, such as HIV or Epstein-Barr virus (EBV), can lead to the activation of B cells. The expression of low CD21 and lack of CD38 may reflect an altered immune response in these infections.

  5. Viral Exposure: Certain viral infections can trigger B cell activation, and low CD21 with absence of CD38 might reflect an intermediate state of activation, where B cells are preparing to respond to the infection but are not yet fully differentiated.

Conclusion:

Elevated levels of Activated CD21 low CD38- Abs generally indicate a scenario where the immune system is activated, but B cells are not fully matured or differentiated. This could be due to chronic inflammation, autoimmune diseases, or certain viral infections. It would be important to correlate these findings with other clinical markers and symptoms for a more comprehensive understanding.

Activated CD21low CD38- B cells are a distinct subset of B lymphocytes associated with chronic immune activation and immune dysregulation. These cells exhibit low CD21 expression, absence of CD38, elevated activation markers like CD80 and CD86, and increased inhibitory receptors such as PD-1 and FCRL4. They produce class-switched antibodies, predominantly IgG and IgA, which often include autoreactive antibodies and those targeting persistent antigens. These cells play a role in chronic inflammation, autoantibody production, and disrupted immune tolerance, commonly linked to autoimmune diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis, as well as chronic infections like HIV and hepatitis C. Reduced responsiveness to signaling pathways and cytokine secretion, including IL-6 and TNF-α, highlight their contribution to immune dysfunction. Monitoring these cells and their antibodies provides insights into chronic immune activation, autoimmune processes, and the efficacy of immunomodulatory therapies, making them valuable markers in diagnostics and disease management.

Activated CD21low CD38- B Cells and Their Antibodies: Markers of Chronic Immune Activation

Activated CD21low CD38- B cells are a distinct subset of B lymphocytes linked to chronic immune activation and immune dysregulation. These cells are characterized by:

  • Low CD21 expression: A complement receptor involved in B cell activation and antigen binding.
  • Absence of CD38: A marker typically associated with B cell activation and differentiation.
  • Elevated activation markers: Such as CD80 and CD86.
  • Increased inhibitory receptors: Including PD-1 and FCRL4.

Antibodies Produced by CD21low CD38- B Cells

  • Isotypes: Primarily class-switched antibodies (e.g., IgG, IgA).
  • Specificity: Includes autoreactive antibodies and those targeting persistent antigens.
  • Affinity: May exhibit reduced affinity maturation due to impaired participation in germinal centers.

Functional Significance

These cells and their antibodies are associated with:

  • Chronic activation: Linked to persistent antigen exposure and inflammation.
  • Exhaustion-like phenotype: Similar to exhausted T cells, they show reduced responsiveness to BCR and CD40 signaling.
  • Cytokine production: Secrete pro-inflammatory cytokines, including IL-6 and TNF-α.

Clinical Associations

  • Autoimmune diseases:
    • Systemic lupus erythematosus (SLE).
    • Rheumatoid arthritis (RA).
    • Sjögren's syndrome.
  • Chronic infections:
    • HIV, hepatitis C virus (HCV), malaria.
  • Primary immunodeficiencies:
    • Common Variable Immunodeficiency (CVID).
    • Age-related immune dysfunction.

Recent Research Developments

  • Single-cell analysis: Highlights heterogeneity within the CD21low CD38- population.
  • Epigenetic studies: Explore regulation of this subset's development and function.
  • Therapeutic targeting: Investigating approaches to modulate or deplete these cells in autoimmune conditions.

Diagnostic and Therapeutic Implications

Monitoring activated CD21low CD38- B cells and their antibodies offers valuable insights into:

  • Chronic immune activation and disease progression in autoimmune disorders and infections.
  • Efficacy of immunomodulatory therapies.
  • Potential biomarkers for immune exhaustion or dysregulation.

Conclusion

Activated CD21low CD38- B cells and their antibodies are critical markers of chronic immune activation and immune dysregulation, playing key roles in autoimmune diseases, chronic infections, and primary immunodeficiencies. Their presence and function provide essential diagnostic and therapeutic insights, though interpretation must account for the broader immune context and clinical presentation.

Activated CD21 low CD38- Abs
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Activated CD21 low CD38- Abs — 10,000+ markers explained
One Activated CD21 low CD38- Abs result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro